Speak with a Defective Drug Specialist
Get answers to legal & medical questions
patient advocate

 

RELATED TOPICS
legal lawyer options about drugrisk

 

Janumet Cancer

Janumet is a popular drug that combines the chemicals in Januvia and Metformin to control high blood sugar associated with type 2 diabetes. Unfortunately, studies now show drugs like this containing sitagliptin may be related to thyroid cancer and pancreatic cancer.

Janumet has been linked to other severe conditions in the past including pancreatitis, lactic acidosis and kidney failure. While the manufacturer, Merck, added warnings for these risks, they have not advised patients of Janumet cancer dangers. Therefore, experts fear thousands could be affected.

Pancreatic cancer, which can spread quickly and is often detected late, is a leading cause of cancer death. Thyroid cancer is usually less severe, but may still require surgery or radioactive medications for treatment.

Common symptoms of either Janumet cancer may include:

  • Jaundice (yellowing of the skin and eyes)
  • Lost weight or appetite
  • Pain in the upper abdomen radiating to the back
  • A lump, pain or swelling in the neck
  • Difficulty swallowing or breathing
  • Hoarseness of voice
  • Frequent cough unrelated to a cold.

If you have experienced any of these symptoms, it is important to speak with your doctor immediately.

Due to the failure of Merck to properly warn of Janumet cancer risks, those affected may also have the right to recover for their damages. Lawyers are currently helping victims learn about their legal rights.

If you were diagnosed with pancreatic or thyroid cancer after taking Janumet, it is important to speak with a lawyer about your legal rights as soon as possible. Time to file a claim is limited. Contact us today.

The FDA first identified a link between pancreatitis and Janumet in 2009. After ordering the manufacturer to add safety warnings, they also required that they conduct additional studies to uncover the risks. However, an FDA violation letter sent in February of 2012 shows Merck was delaying the testing.

In 2011, The University of California at Los Angeles released its own study which raised questions of Janumet cancer risks. Researchers discovered drugs like Janumet and Januvia could increase the risk of pancreatic cancer by 270% and thyroid cancer by 148%.

In 2013, the Journal for the American Medical Association warned that diabetes drugs like Janumet could double the risk of pancreatitis, a major risk factor for pancreatic cancer.

Most recently, the Institute for Safe Medication Practices published findings indicating patients taking drugs like Janumet or Januvia were up to 20 times as likely to report pancreatitis or cancer as those taking older diabetes medications.

If you or a loved one were diagnosed with thyroid cancer or pancreatic cancer after taking Janumet, it is important to speak with a lawyer about your legal options and how much time you have to file a claim.

Drug injury lawsuits can involve litigation against powerful pharmaceutical companies. Therefore, it is important to choose a lawyer with this type of experience. DrugRisk only recommends lawyers and law firms that have already handled lawsuits for diabetes drug cancer.

Contact us today for more information on the warnings, research, side effects and legal news related to Janumet and other diabetes drugs, or to speak with a lawyer. We are available 24 hours a day to help.